avm0703
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2020 (NCT04366115)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04366115 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2020 | AVM Biotechnology LLC, Medpace, Inc. |
| NCT05974410 | N/A | — | AVM Biotechnology LLC |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AVM Biotechnology LLC | For profit | 2 | 2 | 2 | 2020 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1